|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Melinta Therapeutics, Inc (MLNT) |
|
|
$0.11 0.00 (0.00%) as of 4:30 Tue 6/2
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
56,020,000 |
| Market
Cap: |
6.16(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.11 - $0.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sanfilippo Jennifer A |
interim Chief Executive Office |
• • – |
2019-09-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
600 |
|
- |
|
| Johnson John H |
Chief Executive Officer |
• • – |
2019-06-27 |
4 |
S |
$5.57 |
$72,441 |
D/D |
(13,000) |
37,400 |
|
- |
|
| Johnson John H |
Director |
– • – |
2019-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
50,400 |
|
- |
|
| Ferro Kevin |
Director |
– • • |
2018-05-29 |
4 |
B |
$5.00 |
$78,785,000 |
I/I |
15,757,000 |
16,607,959 |
2.25 |
- |
|
| Ferro Kevin |
Director |
– • • |
2018-05-29 |
4 |
B |
$5.00 |
$37,500,000 |
D/D |
7,500,000 |
16,007,237 |
3.92 |
- |
|
| Cammarata Sue |
Chief Medical Officer |
• – – |
2018-05-29 |
4 |
B |
$5.00 |
$20,000 |
D/D |
4,000 |
4,000 |
2.74 |
- |
|
| Zaccardelli David |
Director |
– • – |
2018-05-29 |
4 |
B |
$5.00 |
$200,000 |
D/D |
40,000 |
46,500 |
2.39 |
- |
|
| Wechsler Daniel Mark |
See Remarks |
• • – |
2018-05-29 |
4 |
B |
$5.00 |
$250,000 |
D/D |
50,000 |
50,000 |
2.81 |
- |
|
| Duffy Erin |
Chief Scientific Officer |
• – – |
2018-05-29 |
4 |
B |
$5.00 |
$20,000 |
D/D |
4,000 |
4,000 |
2.74 |
- |
|
| Estrem Paul |
Chief Financial Officer |
• – – |
2018-05-29 |
4 |
B |
$5.00 |
$50,000 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| Gill David N |
Director |
– • – |
2018-05-25 |
4 |
B |
$6.09 |
$30,450 |
D/D |
5,000 |
6,000 |
2.39 |
- |
|
| Ferro Kevin |
Director |
– • • |
2018-01-05 |
4 |
B |
$13.50 |
$54,000,000 |
I/I |
4,000,000 |
8,729,459 |
2.25 |
- |
|
| Ferro Kevin |
Director |
– • • |
2018-01-05 |
4 |
B |
$13.50 |
$24,000,003 |
D/D |
1,777,778 |
8,507,237 |
3.92 |
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2017-03-08 |
4 |
S |
$3.57 |
$356,443 |
I/I |
(99,900) |
0 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2017-03-07 |
4 |
S |
$3.53 |
$176,673 |
I/I |
(50,100) |
99,900 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2017-01-13 |
4 |
S |
$3.40 |
$358,564 |
I/I |
(105,460) |
150,000 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2017-01-06 |
4 |
S |
$3.64 |
$1,592,864 |
I/I |
(437,600) |
255,460 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2017-01-05 |
4 |
S |
$3.20 |
$1,600,000 |
I/I |
(500,000) |
693,060 |
|
- |
|
| Gill David N |
Director |
– • – |
2017-01-03 |
4 |
B |
$2.94 |
$14,720 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| Neff Sherrill P |
Director |
– • – |
2016-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,488 |
2,488 |
|
- |
|
| Neff Sherrill P |
Director |
– • – |
2016-10-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,000,000) |
2,527,154 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2016-03-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(999,955) |
1,193,060 |
|
- |
|
| Moore David |
Chief Commercial Officer |
• – – |
2016-03-01 |
4 |
B |
$16.18 |
$8,090 |
D/D |
500 |
1,500 |
2.74 |
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2016-01-04 |
4 |
AS |
$30.06 |
$25,314 |
D/D |
(842) |
50 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2016-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
842 |
892 |
|
- |
|
46 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
